What's New in Cosmetic Neuromodulators

The presentation discusses recent advancements in cosmetic neuromodulators, highlighting new approvals, including Letty botulinum toxin, Inco for the upper face, and Honour for the platysma. A novel 150K Dalton botulinum toxin A, currently not approved in the U.S. but with several international approvals, is mentioned. It explores the psychological effects of botulinum toxin, noting differences in responses between baby boomers and millennials, with millennials displaying improved satisfaction and results. The importance of treating the platysma muscle, which influences neck appearance and emotional expression, is emphasized, supported by studies showing effective treatment outcomes. New findings indicate improvements in skin texture after treatment with neuromodulators, enhancing patients' self-esteem and reducing social anxiety and depression. The presentation also addresses the cultural influence of social media on aesthetic medicine perceptions and patient choices, underscoring the importance of reputation over influencer endorsements. In conclusion, the evolution of neuromodulator treatments continues to focus on both aesthetic improvements and emotional well-being, with promising new formulations on the horizon.